Get Healthy!

One low-cost intervention could make a difference in America's epidemic of opioid overdoses, a new study suggests.

When health care providers were notified that one of their patients had died from an overdose, they wrote fewer opioid prescriptions for up to a year later.

The University of Southern California (USC) study built upon earlier findings that letters like these could reduc...

COVID-19 patients could soon have a new antiviral pill they can take to guard against severe disease.

The treatment, called VV116, worked as well as Paxlovid in people who were at high risk of severe disease in a phase 3 trial in China.

The trial was a “great success,” study co-author Ren Zhao, a professor at Shanghai Jiao Tong University School of Medicine, said in a

As doctors have tried to steer their chronic pain patients away from highly addictive opioids, many have turned to two antiseizure drugs, but a new review finds they are only "modestly effective" at treating pain.

Gabapentin and pregabalin are being prescribed to manage all types of pain, but clinical trial data shows that the drugs have limited effectiveness, said lead researcher

Doctors are notorious for criticizing patients who don't take medications as prescribed.

But physicians and their families are themselves less likely than everyone else to comply with medication guidelines, a new, large-scale study has found.

People tend to adhere to medication guidelines about 54% of the time, while doctors and their families lag about 4 percentage points behind th...

Shortages of the ADHD drug Adderall are expected to continue for months, forcing families to scramble for ways to deal with their children's attention deficit hyperactivity disorder (ADHD).

The shortage has caused headaches and hassles for parents like San Diego mom Jackie Meader, who has been "flustered, rushed and out of sorts" since her 16-year-old son's prescription ran out about a mo...

An attempt to block California's flavored tobacco ban was stopped Monday when the Supreme Court declined to hear the case.

That now means the ban will go into effect on Dec. 21.

The ban includes everything from candy flavors to menthol in a wide range of tobacco products including vape ...

The antiviral Paxlovid has kept people from getting really sick and dying from COVID-19 since it became available -- at no cost to them.

But by the middle of next year, the U.S. government will stop subsidizing the medication. Instead, it will be billed for like many other medications.

While the Biden administration has paid about $530 for each course of the medication by buying 2...

One of the two most common drugs used to treat age-related macular degeneration (AMD) appears better than the other, a new, small study suggests.

Among 106 patients with "wet" age-related macular degeneration, 50% of those treated with aflibercept (Eylea) could be weaned off the drug after one year, compared with only 17% of those treated with bevacizumab (Avastin), researchers found.

The EpiPen is a known lifesaver when someone with a serious food allergy eats something they can't tolerate.

Yet the auto-injection treatment is greatly underused in the United States, according to a new survey.

Just over half of at-risk adults said they had ever been prescribed the device, researchers found. And more than one-third of severe allergy sufferers mistakenly believe th...

When people with heart failure wind up in the hospital, it tends to become a slippery slope: They are more likely to be readmitted or die within six months during this vulnerable period.

Now, new research shows that ramping up doses of three heart failure medications within two weeks of hospital discharge along with more frequent follow-up visits cuts the risk of both hospital readmission...

Some patients with high blood pressure can't get it under control with standard medications, but a new study shows an experimental drug is up to the task of treating these tough-to-treat cases.

Why do some folks struggle more with managing their high blood pressure than others? When the hypertension i...

Patients with heart failure are often prescribed a diuretic or "water pill" to prevent fluid buildup. A new study has found that two often-prescribed medications work equally well at reducing deaths.

"Given that the two different therapies provide the same effect on outcomes, we shouldn't spend time switching patients from one to the other, and instead concentrate on giving the right dos...

The antiviral pill Paxlovid not only reduces hospitalization and death after catching COVID-19: New research shows it also cuts the chances of long COVID by roughly 25%.

The drug, which combines a newer antiviral called nirmatrelvir with an older medication known as ritonavir, del...

A new study has shown the blood pressure drug telmisartan may offer new hope as an Alzheimer's treatment in Black patients. It did not show the same benefit in white people.

Learning how people from different ethnic groups respond to the same drug could be key in the fight against Alzheimer's disease, researchers say. Even though Black people are more likely than white folks to develop th...

Years of litigation over the opioid epidemic could end soon, as the national pharmacy chains CVS and Walgreens announced Wednesday that each company has agreed to a nearly $5 billion settlement.

While neither of the companies admitted wrongdoing, the settlements are part of the fight over the drug industry's role in the epidemic that has led to 500,000 U.S. deaths in the past 20 years, t...

For the millions of people who live with vitiligo, a disease that robs the skin of its natural color, a newly approved cream called ruxolitinib (Opzelura) is quickly becoming a game changer.

The U.S. Food and Drug Administration